Gulf Pharmaceutical Industries P.S.C. (ADX: JULPHAR)
Health Care · Pharmaceuticals · AE
AED1.02
-0.97% today · -20.3% 1Y
Gulf Pharmaceutical Industries P.S.C. (ADX: JULPHAR) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $320.80M.
Over the last twelve months the share price has lost 20.3%, trading between 0.96 and 1.47.
Tweenvest scores Gulf Pharmaceutical Industries P.S.C. across four factors: quality 63/100, value 59/100, growth 0/100. Its strongest factor is quality.
JULPHAR price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $320.80M
- Revenue (TTM)
- $299.83M
- P/E
- 12.39
- EPS
- 0.08
- Dividend yield
- —
- Beta (5Y)
- -0.13
- 52-week high
- AED1.47
- 52-week low
- AED0.96
- Avg volume (3M)
- —
- Shares outstanding
- 1.16B
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Abbott Laboratories (Pakistan) LimitedKASE: ABOT | $327.56M | PKRs926.50 | +0.19% |
| Ind-Swift Laboratories LimitedNSEI: INDSWFTLAB | $324.28M | Rs360.90 | -8.67% |
| Ouro Fino Saúde Animal Participações S.A.BOVESPA: OFSA3 | $323.80M | R$30.00 | +7.57% |
| Solara Active Pharma Sciences LimitedNSEI: SOLARA | $321.23M | Rs644.35 | -9.86% |
| HLB Pharmaceutical Co., Ltd.KOSDAQ: A047920 | $320.33M | ₩13,130.00 | +31.17% |
| Standard Chemical & Pharmaceutical Co., Ltd.TWSE: 1720 | $317.99M | NT$56.90 | +1.43% |
| Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,LtdSZSE: 301130 | $316.94M | CN¥28.12 | -1.37% |
| Shukra Pharmaceuticals LimitedBSE: 524632 | $304.29M | Rs66.99 | +8.33% |
Figures last refreshed Oct 11, 2026.